Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone marrow transplantation]

B Speck1, A Gratwohl, A Tichelli

  • 1Departement für Innere Medizin, Kantonsspital Basel.

Schweizerische Medizinische Wochenschrift
|August 19, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Bone marrow transplantation·2016
Same author

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Leukemia & lymphoma·2016

Bone marrow transplantation (BMT) is a key therapy for blood disorders and cancers. This study reviews BMT indications, techniques, and outcomes, showing long-term survival and disease-free rates for patients receiving allogeneic transplants.

Area of Science:

  • Hematology and Oncology
  • Transplantation Medicine
  • Immunology

Context:

  • Bone marrow transplantation (BMT) has transitioned from experimental to a standard treatment for various hematological, immunological, and metabolic disorders, as well as certain solid tumors.
  • The report analyzes 397 BMT procedures (357 allogeneic, 40 autologous) conducted between 1973 and 1995.

Purpose:

  • To summarize the primary indications for autologous and allogeneic BMT.
  • To outline the prerequisites, techniques, complications, and management strategies associated with BMT.
  • To present the outcomes and prognostic factors of BMT based on a historical cohort.

Summary:

  • Key prognostic factors identified include disease stage, patient age, and histocompatibility.
  • Allogeneic BMT from HLA-identical siblings achieved a 15-year survival rate of 50%, with 80% of patients disease-free and socially reintegrated.

Related Experiment Videos

  • Emerging strategies involve unrelated HLA-compatible donors and the use of mobilized peripheral blood stem cells.

    • Impact:

    • Establishes BMT as a viable long-term therapeutic option for severe hematological and immunological conditions.
    • Highlights the critical role of donor matching and early disease intervention in optimizing BMT success.
    • Informs future research directions, including the exploration of alternative stem cell sources and donor types.